John C. Morris

Physiology · 2001–2020

A researcher in the Science corpus: 48 papers; trusts 22 researchers and is trusted by 25 researchers here, as inferred from the citation graph.

Subfields

• Physiology — 311 citations into it; #407 of 2,276 by trust here, #13 by citations
• Psychiatry and Mental health — 223 citations into it; #65 of 1,338 by trust here, #4 by citations
• Neurology — 162 citations into it
• Cognitive Neuroscience — 158 citations into it; #1,993 of 10,852 by trust here, #248 by citations
• Molecular Biology — 153 citations into it; #11,929 of 17,773 by trust here, #2,333 by citations
• Radiology, Nuclear Medicine and Imaging — 108 citations into it; #619 of 3,265 by trust here, #165 by citations
• Computer Vision and Pattern Recognition — 37 citations into it

Whom John C. Morris trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Randy L. Buckner
2. Ronald C. Petersen
3. Bruce Fischl
4. David H. Salat
5. H. Braak
6. Denise Head
7. D. Holtzman
8. Abraham Z. Snyder
9. Daniel S. Marcus
10. Anne M. Fagan

Who trusts John C. Morris overall

1. Randy L. Buckner
2. Daniel S. Marcus
3. D. Holtzman
4. Marcus E. Raichle
5. Anders M. Fjell
6. Guha Balakrishnan
7. David H. Salat
8. Clifford R. Jack Jr.

Papers from John C. Morris's perspective

Ordered by how strongly the researchers John C. Morris trusts endorse each paper. Same corpus, a different order for every researcher.

1. Neuropathological stageing of Alzheimer-related changes
2. Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. (Cerebral Cortex)
3. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis (NeuroImage)
4. Measuring the thickness of the human cerebral cortex from magnetic resonance images. (Proceedings of the National Academy of Sciences of the United States of America)
5. Dynamics of Gray Matter Loss in Alzheimer's Disease (Journal of Neuroscience)
6. Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI (Proceedings of the National Academy of Sciences of the United States of America)
7. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual… (NeuroImage)
8. Thinning of the cerebral cortex in aging. (Cerebral Cortex)
9. Cortical networks for working memory and executive functions sustain the conscious resting state in man. (Brain Research Bulletin)
10. Functional connectivity in the resting brain: A network analysis of the default mode hypothesis (Proceedings of the National Academy of Sciences of the United States of America)

Their papers

• Human apoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) — 1,198 citations
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) — 1,887 citations
• Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo (2006) — 613 citations
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes (2009) — 1,794 citations
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease (2009) — 1,585 citations
• Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
• Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis (2002) — 609 citations
• MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide. (2020) — 356 citations
• APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline (2020) — 1,053 citations
• Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction (2019) — 1,438 citations
• High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis (2019) — 750 citations
• Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) — 781 citations
• OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease (2019) — 758 citations
• Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set (2018) — 421 citations
• ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy (2017) — 1,058 citations
• Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease (2016) — 654 citations
• Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) — 1,062 citations
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2013) — 1,348 citations
• Sleep quality and preclinical Alzheimer Disease (2013) — 685 citations
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) — 1,882 citations